Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Decision Support Tool for Blood Thinner Choice in Atrial Fibrillation

Tests a decision support tool to help people with atrial fibrillation weigh blood thinner choices.

Plain-language title generated from the registry record
Registry title: Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Key facts

Where
Durham, United StatesSee the site

Where in United States

  • Duke University Medical CenterDurham, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Duke University
Trial code
NCT04956978
Record updated
9 September 2026
Original description
The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures.Read full original descriptionShow less

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation Use in Patients With Non-valvular Atrial Fibrillation

The study is a pilot analysis using a decision on the risk and benefits of oral anticoagulation for stroke reduction for patients with non-valvular atrial fibrillation. This study is a feasibility and acceptability analysis but will also measure preliminary effectiveness measures.

The investigator hypothesizes that a patient decision support tool will increase decision quality and secondarily increase the use of oral anticoagulation in Black patients with non-valvular atrial fibrillation.

Inclusion: Black and White adults greater than or equal to 18 years of age; Clinical diagnosis of NVAF; CHA2DS2-VASc score greater than or equal to 2; New patient visit for initiation of oral anticoagulation at primary care and cardiology clinics.

Exclusion: Unable to speak English; Unable to provide informed consent.

ClinicalTrials.gov NCT04956978